East China medicine: the subsidiary ornidazole tablets passed the conformity evaluation of generic drugs
Financial Associated Press, September 29 - East China medicine announced that the ornidazole tablets produced by the company's wholly-owned subsidiary East China Medicine (Xi'an) Bohua Pharmaceutical Co., Ltd. passed the consistency evaluation of generic drug quality and efficacy. Ornidazole is used to treat a variety of diseases caused by anaerobic infection, such as Trichomonas urogenital tract infection in men and women, Giardia flagellate infection and so on.
This text is a result of machine translation.
Related companies：
In-depth
Technology
INMO: No Wires, No Limits, Pure Reality
In the realm of technology today, Augmented Reality (AR) has consistently captured our attention as one of the revolutionary technologies with the potential to reshape our way of life. INMO, (Chinese: 影目科技), one of the frontrunners in the AR glasses domain, has recently unveiled a paradigm-shifting AR eyewear product INMO Go, earning widespread attention.
Nov 28, 2023 06:33 AM
Jan 06, 2023 08:30 AM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Nov 10, 2022 02:39 PM
Insight
Technology
Consumer Electronics: ESG Emerging as a Hidden Highlight
In the face of the global consumer electronics industry in the cold, the future is more than relying on technological iteration and consumer upgrades, ESG and sustainable is providing new possibilities for the development of the industry.
Nov 30, 2023 10:11 PM
Insight
Sunshine City responded to the rumor that the interest extension plan was approved: the news is true
Briefing Jan 18, 2022 01:49 PM
· Technology
The trading amount of well-off shares was nearly 1.5 billion
See more
Read next
Insight
In-depth
Insight
In-depth
Insight
In-depth
Insight
In-depth